Annexon, Inc. Files Q3 2024 10-Q
Ticker: ANNX · Form: 10-Q · Filed: Nov 14, 2024 · CIK: 1528115
Sentiment: neutral
Topics: 10-Q, financials, biotech
TL;DR
Annexon's Q3 10-Q is in. Check financials.
AI Summary
Annexon, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported its financial position, including cash and cash equivalents and common stock details. Key dates mentioned include September 30, 2024, and March 31, 2023, for various equity and asset valuations.
Why It Matters
This filing provides investors with an update on Annexon's financial health and operational status as of the end of the third quarter of 2024.
Risk Assessment
Risk Level: low — This is a standard quarterly financial filing with no immediate red flags.
Key Numbers
- 2024-09-30 — Reporting Period End Date (Indicates the financial snapshot date.)
- 2023-03-31 — Comparative Balance Sheet Date (Used for year-over-year or period-over-period comparisons.)
Key Players & Entities
- Annexon, Inc. (company) — Filer of the 10-Q
- 2024-09-30 (date) — End of reporting period
- 2023-03-31 (date) — Comparative financial reporting date
FAQ
What was Annexon, Inc.'s cash and cash equivalents balance as of September 30, 2024?
The filing indicates 'us-gaap:CashAndCashEquivalentsMember' for '2024-09-30', but the specific dollar amount is not provided in this header data.
What is the total number of common shares outstanding as of September 30, 2024?
The filing references 'us-gaap:CommonStockMember' for '2024-09-30', but the exact number of shares is not detailed in this extract.
What was the value of Annexon's short-term investments as of December 31, 2023?
The filing mentions 'us-gaap:ShortTermInvestmentsMember' for '2023-12-31', but the specific dollar amount is not present in this header.
What is the company's fiscal year end date?
Annexon, Inc.'s fiscal year ends on December 31.
Where is Annexon, Inc. headquartered?
Annexon, Inc. is located in Brisbane, California.
Filing Stats: 4,388 words · 18 min read · ~15 pages · Grade level 16.5 · Accepted 2024-11-14 16:10:22
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share ANNX The Nasdaq Stock Mar
Filing Documents
- annx-20240930.htm (10-Q) — 2266KB
- annx-ex31_1.htm (EX-31.1) — 16KB
- annx-ex31_2.htm (EX-31.2) — 16KB
- annx-ex32_1.htm (EX-32.1) — 14KB
- 0000950170-24-127057.txt ( ) — 7420KB
- annx-20240930.xsd (EX-101.SCH) — 934KB
- annx-20240930_htm.xml (XML) — 1154KB
—FINANCIAL INFORMATION
PART I—FINANCIAL INFORMATION Item 1.
Financial Statements (Unaudited)
Financial Statements (Unaudited) Condensed Consolidated Balance Sheets 1 Condensed Consolidated Statements of Operations 2 Condensed Consolidated Statements of Comprehensive Loss 3 Condensed Consolidated Statements of Stockholders' Equity 4 Condensed Consolidated Statements of Cash Flows 6 Notes to Condensed Consolidated Financial Statements 7 Item 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations 17 Item 3.
Quantitative and Qualitative Disclosures About Market Risk
Quantitative and Qualitative Disclosures About Market Risk 25 Item 4.
Controls and Procedures
Controls and Procedures 25
—OTHER INFORMATION
PART II—OTHER INFORMATION Item 1.
Legal Proceedings
Legal Proceedings 26 Item 1A.
Risk Factors
Risk Factors 26 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 69 Item 3. Defaults Upon Senior Securities 69 Item 4. Mine Safety Disclosures 69 Item 5. Other Information 69 Item 6. Exhibits 70
SIGNATURES
SIGNATURES 71 In this Quarterly Report on Form 10-Q, "we," "our," "us," "Annexon" and the "Company" refer to Annexon, Inc. and its consolidated subsidiary. Annexon, Annexon, Inc., the Annexon logo and other trade names, trademarks or service marks of Annexon are the property of Annexon, Inc. This report contains references to our trademarks and to trademarks belonging to other entities. Trade names, trademarks and service marks of other companies appearing in this report are the property of their respective holders. We do not intend our use or display of other companies' trade names or trademarks to imply a relationship with, or endorsement or sponsorship of us by, any other companies. ANNEXON, INC. Condensed Consolidated Balance Sheets (in thousands) September 30, 2024 December 31, 2023 (Unaudited) Assets Current assets: Cash and cash equivalents $ 79,540 $ 225,110 Short-term investments 260,576 34,606 Prepaid expenses and other current assets 4,176 4,144 Total current assets 344,292 263,860 Restricted cash 1,032 1,032 Property and equipment, net 13,169 14,773 Operating lease right-of-use assets 17,050 18,009 Other non-current assets 3,233 — Total assets $ 378,776 $ 297,674 Liabilities and Stockholders' Equity Current liabilities: Accounts payable $ 6,748 $ 5,487 Accrued and other current liabilities 10,861 10,276 Operating lease liabilities, current 2,437 2,165 Total current liabilities 20,046 17,928 Operating lease liabilities, non-current 27,170 29,190 Total liabilities 47,216 47,118 Commitments and contingencies (Note 5) Stockholders' equity: Common stock 106 78 Additional paid-in capital 993,486 823,029 Accumulated other comprehensive loss 77 ( 52 ) Accumulated deficit ( 662,109 ) ( 572,499 ) Total stockholders' equity 331,560 250,556 Total liabilities and stockholders' equity $ 378,776 $